Risk factors for non-adherence to antidepressant treatment in patients with mood disorders
- 8 September 2013
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 70 (1) , 89-98
Abstract
Purpose Adherence to antidepressant therapy by patients with depressive disorders is essential not only to achieve a positive patient outcome but also to prevent a relapse. The aim of this study was to identify potential modelling factors influencing adherence to antidepressant treatment by patients with mood disorders in the community mental health care setting Methods A total of 160 consecutive psychiatric outpatients attending two Community Mental Health Centres on Tenerife Island between September 2011 and May 2012 were asked to participate in the study; of these, 145 accepted. The Morisky self-report scale was used to assess adherence. The potential predictors examined included socio-demographic, clinical and therapeutic variables. The Clinical Global Impression-Severity and -Improvement scales and the Beck Depression Inventory were used for clinical assessment. Drug treatment side-effects were assessed using the “Self-report Antidepressant Side-Effect Checklist.” All participants were also asked to complete the "Drug Attitude Inventory" (DAI), "Beliefs about Medicine Questionnaire" (BMQ), and "Leeds Attitude towards concordance Scale". Discriminant analyses were performed to predict non-adherence. Results There was no clear correlation between adherence and the socio-demographic variables examined, but adherence was related to a positive attitude of the patients towards his/her treatment (DAI) and low scores in the BMQ-Harm and -Concern subscales. Non-adherence was also related to an increasing severity of depression and to the presence and severity of side-effects. Conclusions Among our study cohort, the profiles of adherent patients to antidepressant treatment were more closely associated with each patient’s attitudes and beliefs than to objective socio-demographic variables. The severity of depression played a relevant role in adherence, but whether this role is direct or an interaction with several concurrent factors is not yet clear. Side-effects were also closely related to adherence, as conditioned by frequent polypharmacy.Keywords
This publication has 49 references indexed in Scilit:
- Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studiesPatient Preference and Adherence, 2013
- Adherence to Medication in Depressive PatientsJournal of Clinical Psychopharmacology, 2011
- Beliefs about medications predict adherence to antidepressants in older adultsInternational Psychogeriatrics, 2011
- Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd Study)BMC Psychiatry, 2011
- Maintenance Treatment of Depression in Old AgeArchives of General Psychiatry, 2011
- Patients' Beliefs about Medicines in a primary care setting in GermanyJournal of Evaluation in Clinical Practice, 2010
- Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectActa Psychiatrica Scandinavica, 2004
- Polypharmacy and Medication Adherence. Small Steps on a Long RoadJournal of General Internal Medicine, 2001
- The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medicationPsychology & Health, 1999
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986